Key Events This Week
15 Jun: Technical momentum shifts amid mixed market signals
16 Jun: Upgrade to Hold as technicals improve and valuation adjusts
16 Jun: Signs of technical momentum shift with 4.08% price gain
19 Jun: Week closes at Rs.2,277.65 (+3.08% weekly gain)

RPG Life Sciences Ltd Upgraded to Hold as Technicals Improve and Valuation Adjusts
2026-06-16 08:44:25RPG Life Sciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and valuation metrics despite flat recent financial performance. The company’s evolving market dynamics and relative valuation position have prompted analysts to revise their outlook, signalling cautious optimism for investors in this small-cap pharmaceutical player.
Read full news article
RPG Life Sciences Ltd Shows Signs of Technical Momentum Shift Amid Mixed Indicator Signals
2026-06-16 08:02:37RPG Life Sciences Ltd has demonstrated a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for this small-cap pharmaceutical player.
Read full news article
RPG Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-06-15 08:02:06RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day gain of 0.42%, the stock’s technical parameters reveal a nuanced outlook that investors should carefully consider amid evolving market dynamics.
Read full news article
RPG Life Sciences Ltd is Rated Sell
2026-06-14 10:10:29RPG Life Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleRPG Life Sciences Gains 2.10%: 2 Key Factors Driving the Week’s Momentum
2026-06-13 13:12:13
Key Events This Week
8 June: Stock opens at Rs.2,086.45, down 3.58% amid market pressure
9 June: Valuation shifts to attractive despite price dip
11 June: Intraday high of Rs.2,278.45 with 7.77% surge
12 June: Week closes at Rs.2,209.50, up 0.42% on the day

RPG Life Sciences Ltd Surges 7.77% to Day's High of Rs 2278.45 — Outperforms Sector by 6.49 Percentage Points
2026-06-11 09:51:26The Sensex declined by 0.31% on 11 Jun 2026, while RPG Life Sciences Ltd surged 7.77%, marking a notable 6.49-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which has been on a three-day winning streak, accumulating an 8.21% return in that period.
Read full news article
RPG Life Sciences Ltd Valuation Shifts to Attractive Amid Market Pressure
2026-06-09 08:00:09RPG Life Sciences Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite recent share price declines. This change comes amid broader sector challenges and a mixed performance relative to peers, highlighting a potential opportunity for investors seeking value in the Pharmaceuticals & Biotechnology space.
Read full news article
RPG Life Sciences Ltd is Rated Sell
2026-06-03 10:10:03RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news articleRPG Life Sciences Limited - Other General Purpose
28-Nov-2019 | Source : NSERPG Life Sciences Limited has submitted to the Exchange a copy of disclosure of Related Party Transactions for the half year ended September 30, 2019.
RPG Life Sciences Limited - Updates
01-Nov-2019 | Source : NSERPG Life Sciences Limited has informed the Exchange regarding 'In terms of the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and half year ended September 30, 2019.
RPG Life Sciences Limited - Outcome of Board Meeting
31-Oct-2019 | Source : NSERPG Life Sciences Limited has informed the Exchange regarding Board meeting held on October 30, 2019.
Corporate Actions
No Upcoming Board Meetings
RPG Life Sciences Ltd has declared 250% dividend, ex-date: 27 Jun 25
No Splits history available
No Bonus history available
No Rights history available






